Related Experiment Video
Updated: Sep 30, 2025

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
Published on: June 6, 2025
Free ISG15 and Protein ISGylation Emerging in SARS-CoV-2 Infection
1Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México (UACM), CDMX, México.
Abstract:
Interferon-simulated gene 15 (ISG15) belongs to the family of ubiquitin-like proteins. ISG15 acts as a cytokine and modifies proteins through ISGylation. This posttranslational modification has been associated with antiviral and immune response pathways. In addition, it is known that the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encodes proteases critical for viral replication. Consequently, these proteases are also central in the progression of coronavirus disease 2019 (COVID-19). Interestingly, the protease SARS-CoV-2-PLpro removes ISG15 from ISGylated proteins such as IRF3 and MDA5, affecting immune and antiviral defense from the host. Here, the implications of ISG15, ISGylation, and generation of SARS-CoV-2-PLpro inhibitors in SARS-CoV-2 infection are discussed.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protease PLpro removes ISG15, impacting host antiviral defenses. Developing SARS-CoV-2-PLpro inhibitors may restore immune responses against COVID-19.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Interferon-simulated gene 15 (ISG15) is a ubiquitin-like protein involved in antiviral and immune responses.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes proteases for viral replication, crucial for COVID-19 progression.
Purpose of the Study:
- To discuss the role of ISG15 and ISGylation in the context of SARS-CoV-2 infection.
- To explore the implications of SARS-CoV-2 protease PLpro in deISGylating host proteins and its effect on immune evasion.
- To highlight the potential of developing SARS-CoV-2-PLpro inhibitors for therapeutic strategies.
Main Methods:
- Literature review and discussion of existing research on ISG15, ISGylation, and SARS-CoV-2.
- Analysis of the mechanism by which SARS-CoV-2 PLpro interacts with and modifies ISGylated proteins.
- Exploration of the functional consequences of ISG15 removal on host antiviral pathways.
Main Results:
- SARS-CoV-2 PLpro effectively removes ISG15 from host proteins like IRF3 and MDA5.
- This deISGylation activity by SARS-CoV-2 PLpro impairs host immune and antiviral defenses.
- ISG15 modification and its removal by viral proteases are critical factors in SARS-CoV-2 pathogenesis.
Conclusions:
- ISG15 and ISGylation are key components of the host antiviral response targeted by SARS-CoV-2.
- Inhibition of SARS-CoV-2 PLpro activity presents a promising therapeutic avenue to restore host immunity against COVID-19.
- Further research into ISG15-PLpro interactions can lead to novel strategies for combating SARS-CoV-2 infection.
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Leaky Scanning
Protein Glycosylation
Glycosylation occurs in...
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Regulation of the Unfolded Protein Response

